Loading...
XSTOSPEC
Market cap24mUSD
Dec 23, Last price  
2.78SEK
1D
0.72%
1Q
23.01%
Jan 2017
61.63%
IPO
91.72%
Name

SpectraCure AB (publ)

Chart & Performance

D1W1MN
XSTO:SPEC chart
P/E
—
P/S
849.14
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
4.38%
Rev. gr., 5y
-11.81%
Revenues
318k
-41.00%
1,490,125476,195778,500172,912258,953596,0007631,2110539,000318,000
Net income
-20m
L-19.29%
-5,732,138-4,345,965-5,884,582-6,372,149-8,696,619-9,610,000-13,685,000-15,407,000-23,341,000-25,326,000-20,441,000
CFO
-19m
L-18.65%
0-604,491-9,714,363-19,596,2366,325,959-8,972,000-10,055,000-9,404,000-18,603,000-22,962,000-18,680,000

Profile

SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
URL
https://spectracure.com/
IPO date
Jul 01, 2015
Employees
13
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
318
-41.00%
539
 
Cost of revenue
9,541
8,575
9,304
Unusual Expense (Income)
NOPBT
(9,223)
(8,036)
(9,304)
NOPBT Margin
Operating Taxes
(21)
(53)
(5)
Tax Rate
NOPAT
(9,202)
(7,983)
(9,299)
Net income
(20,441)
-19.29%
(25,326)
8.50%
(23,341)
51.50%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,804
BB yield
-0.32%
Debt
Debt current
2,320
2,430
2,414
Long-term debt
11,114
2,970
7,392
Deferred revenue
Other long-term liabilities
Net debt
(44,211)
(89,010)
(119,886)
Cash flow
Cash from operating activities
(18,680)
(22,962)
(18,603)
CAPEX
(15,767)
(10,117)
(8,492)
Cash from investing activities
(15,562)
(11,347)
(8,492)
Cash from financing activities
(1,987)
(2,203)
(453)
FCF
(12,198)
(5,762)
(8,766)
Balance
Cash
56,951
93,180
129,692
Long term investments
694
1,230
Excess cash
57,629
94,383
129,692
Stockholders' equity
(128,154)
(107,715)
(82,336)
Invested Capital
264,730
260,714
262,916
ROIC
ROCE
EV
Common stock shares outstanding
97,132
97,132
97,132
Price
3.86
-23.11%
5.02
-14.63%
5.88
-64.92%
Market cap
374,928
-23.11%
487,601
-14.63%
571,134
-63.12%
EV
330,717
398,591
451,248
EBITDA
(6,561)
(5,104)
(6,637)
EV/EBITDA
Interest
522
182
245
Interest/NOPBT